 Benjamin Frank
Concepts (229)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension, Pulmonary | 14 | 2023 | 1736 | 2.960 |
Why?
| | Ventricular Dysfunction, Left | 6 | 2022 | 371 | 1.730 |
Why?
| | Heart Defects, Congenital | 7 | 2023 | 683 | 1.450 |
Why?
| | Hernias, Diaphragmatic, Congenital | 2 | 2023 | 184 | 1.400 |
Why?
| | Endothelin-1 | 2 | 2022 | 168 | 1.260 |
Why?
| | Ventricular Dysfunction, Right | 4 | 2023 | 221 | 1.120 |
Why?
| | Fontan Procedure | 4 | 2023 | 168 | 1.090 |
Why?
| | Cardiac Surgical Procedures | 5 | 2022 | 414 | 1.020 |
Why?
| | Matrix Metalloproteinase 8 | 1 | 2023 | 9 | 0.880 |
Why?
| | Blood Proteins | 2 | 2020 | 222 | 0.810 |
Why?
| | Aortic Coarctation | 2 | 2023 | 70 | 0.800 |
Why?
| | Heart Bypass, Right | 1 | 2022 | 17 | 0.780 |
Why?
| | Pulmonary Artery | 6 | 2021 | 1024 | 0.780 |
Why?
| | Cardiac Catheterization | 3 | 2022 | 545 | 0.780 |
Why?
| | Infant, Premature, Diseases | 2 | 2023 | 88 | 0.780 |
Why?
| | Echocardiography | 5 | 2023 | 569 | 0.760 |
Why?
| | Hemodynamics | 8 | 2022 | 1015 | 0.720 |
Why?
| | Ventricular Function, Left | 4 | 2023 | 477 | 0.720 |
Why?
| | Pulmonary Wedge Pressure | 1 | 2020 | 64 | 0.700 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2023 | 241 | 0.700 |
Why?
| | Cardiopulmonary Bypass | 6 | 2022 | 174 | 0.700 |
Why?
| | Heart Diseases | 1 | 2023 | 329 | 0.690 |
Why?
| | Heart Function Tests | 1 | 2019 | 60 | 0.660 |
Why?
| | Infant | 16 | 2023 | 7944 | 0.660 |
Why?
| | Scurvy | 1 | 2019 | 12 | 0.630 |
Why?
| | Interleukin-1 Receptor-Like 1 Protein | 1 | 2019 | 22 | 0.630 |
Why?
| | Child | 23 | 2023 | 18404 | 0.620 |
Why?
| | Bronchopulmonary Dysplasia | 2 | 2023 | 333 | 0.610 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2019 | 102 | 0.610 |
Why?
| | Diagnostic Imaging | 1 | 2020 | 278 | 0.590 |
Why?
| | Prospective Studies | 10 | 2023 | 6195 | 0.580 |
Why?
| | Ventricular Remodeling | 1 | 2019 | 224 | 0.550 |
Why?
| | Infant, Newborn | 11 | 2023 | 5038 | 0.510 |
Why?
| | Heart Ventricles | 6 | 2023 | 723 | 0.480 |
Why?
| | Humans | 44 | 2023 | 114049 | 0.440 |
Why?
| | Pain | 1 | 2019 | 701 | 0.430 |
Why?
| | Familial Primary Pulmonary Hypertension | 4 | 2022 | 191 | 0.430 |
Why?
| | Matrix Metalloproteinase 7 | 2 | 2023 | 25 | 0.400 |
Why?
| | Treatment Outcome | 9 | 2022 | 9049 | 0.400 |
Why?
| | Retrospective Studies | 11 | 2023 | 12521 | 0.390 |
Why?
| | Ventricular Function, Right | 3 | 2023 | 256 | 0.380 |
Why?
| | Pulmonary Veins | 2 | 2023 | 83 | 0.360 |
Why?
| | Atrial Function, Right | 2 | 2021 | 12 | 0.360 |
Why?
| | Myocardial Contraction | 3 | 2020 | 318 | 0.340 |
Why?
| | Postoperative Complications | 5 | 2021 | 2122 | 0.340 |
Why?
| | Adolescent | 12 | 2023 | 17802 | 0.340 |
Why?
| | Pulmonary Valve | 1 | 2010 | 89 | 0.320 |
Why?
| | Biomarkers | 5 | 2023 | 3397 | 0.320 |
Why?
| | Tissue Engineering | 1 | 2010 | 364 | 0.270 |
Why?
| | Proteomics | 2 | 2023 | 815 | 0.270 |
Why?
| | Vascular Stiffness | 2 | 2021 | 410 | 0.260 |
Why?
| | Magnetic Resonance Imaging, Cine | 3 | 2023 | 172 | 0.260 |
Why?
| | Hemorrhage | 2 | 2021 | 600 | 0.260 |
Why?
| | Predictive Value of Tests | 4 | 2023 | 1791 | 0.250 |
Why?
| | Male | 18 | 2023 | 55398 | 0.240 |
Why?
| | Acute Kidney Injury | 2 | 2022 | 637 | 0.240 |
Why?
| | Hypoxia | 2 | 2022 | 956 | 0.240 |
Why?
| | Nitric Oxide | 2 | 2021 | 817 | 0.240 |
Why?
| | Magnetic Resonance Imaging | 6 | 2023 | 3039 | 0.240 |
Why?
| | Prognosis | 2 | 2023 | 3315 | 0.230 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2023 | 25 | 0.220 |
Why?
| | Kynurenine | 2 | 2021 | 81 | 0.210 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2023 | 27 | 0.210 |
Why?
| | Stroke Volume | 2 | 2023 | 513 | 0.210 |
Why?
| | Tryptophan | 2 | 2022 | 136 | 0.210 |
Why?
| | Female | 17 | 2023 | 59326 | 0.210 |
Why?
| | Stenosis, Pulmonary Vein | 1 | 2023 | 17 | 0.210 |
Why?
| | Computed Tomography Angiography | 1 | 2023 | 100 | 0.210 |
Why?
| | Infant, Extremely Premature | 1 | 2023 | 57 | 0.210 |
Why?
| | Extracellular Matrix Proteins | 1 | 2023 | 126 | 0.200 |
Why?
| | Ventricular Outflow Obstruction | 1 | 2022 | 38 | 0.200 |
Why?
| | Atrioventricular Block | 1 | 2022 | 37 | 0.200 |
Why?
| | Fetal Diseases | 1 | 2023 | 146 | 0.200 |
Why?
| | Phenylpropionates | 1 | 2022 | 16 | 0.200 |
Why?
| | Infant, Newborn, Diseases | 1 | 2023 | 104 | 0.190 |
Why?
| | Phosphoproteins | 1 | 2003 | 293 | 0.190 |
Why?
| | Pyridazines | 1 | 2022 | 46 | 0.190 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2003 | 474 | 0.190 |
Why?
| | Tissue Inhibitor of Metalloproteinases | 1 | 2021 | 16 | 0.190 |
Why?
| | Aorta, Thoracic | 1 | 2023 | 257 | 0.190 |
Why?
| | Ventricular Function | 1 | 2021 | 57 | 0.180 |
Why?
| | Postoperative Period | 1 | 2022 | 288 | 0.180 |
Why?
| | Administration, Inhalation | 2 | 2021 | 637 | 0.180 |
Why?
| | Protein Conformation | 1 | 2003 | 803 | 0.180 |
Why?
| | Antihypertensive Agents | 2 | 2022 | 428 | 0.180 |
Why?
| | Risk Factors | 4 | 2023 | 8614 | 0.180 |
Why?
| | Metabolomics | 3 | 2021 | 511 | 0.180 |
Why?
| | Matrix Metalloproteinases | 1 | 2021 | 89 | 0.180 |
Why?
| | Pulmonary Atresia | 1 | 2020 | 20 | 0.180 |
Why?
| | Preoperative Period | 1 | 2020 | 102 | 0.170 |
Why?
| | Heart Atria | 1 | 2021 | 107 | 0.170 |
Why?
| | Lung | 3 | 2023 | 3521 | 0.170 |
Why?
| | Extracellular Matrix | 1 | 2023 | 436 | 0.170 |
Why?
| | Electrophysiological Phenomena | 1 | 2019 | 48 | 0.170 |
Why?
| | Intensive Care Units, Neonatal | 2 | 2018 | 176 | 0.160 |
Why?
| | Infant, Premature | 2 | 2023 | 478 | 0.160 |
Why?
| | Hypoplastic Left Heart Syndrome | 1 | 2020 | 114 | 0.160 |
Why?
| | Regional Blood Flow | 1 | 2021 | 421 | 0.160 |
Why?
| | Gingiva | 1 | 2019 | 22 | 0.160 |
Why?
| | Aortic Valve Stenosis | 1 | 2022 | 269 | 0.160 |
Why?
| | Mechanical Phenomena | 1 | 2019 | 80 | 0.160 |
Why?
| | Coronary Care Units | 1 | 2018 | 13 | 0.160 |
Why?
| | Models, Cardiovascular | 1 | 2020 | 179 | 0.160 |
Why?
| | Cholecalciferol | 1 | 2019 | 47 | 0.150 |
Why?
| | Pulmonary Alveoli | 1 | 2021 | 372 | 0.150 |
Why?
| | Chest Pain | 1 | 2019 | 82 | 0.150 |
Why?
| | Alkaline Phosphatase | 1 | 2019 | 142 | 0.150 |
Why?
| | Ascorbic Acid | 1 | 2019 | 110 | 0.150 |
Why?
| | Endotoxemia | 1 | 2019 | 86 | 0.150 |
Why?
| | Endotoxins | 1 | 2019 | 211 | 0.150 |
Why?
| | Child, Preschool | 6 | 2022 | 9115 | 0.150 |
Why?
| | Heart Transplantation | 1 | 2023 | 670 | 0.140 |
Why?
| | Iron | 1 | 2019 | 232 | 0.140 |
Why?
| | Leg | 1 | 2019 | 224 | 0.140 |
Why?
| | Length of Stay | 2 | 2018 | 957 | 0.140 |
Why?
| | Vasodilator Agents | 1 | 2019 | 302 | 0.140 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2018 | 465 | 0.140 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2021 | 684 | 0.140 |
Why?
| | Case-Control Studies | 2 | 2020 | 3003 | 0.140 |
Why?
| | Down Syndrome | 1 | 2021 | 335 | 0.130 |
Why?
| | Tandem Mass Spectrometry | 1 | 2018 | 410 | 0.130 |
Why?
| | Risk | 1 | 2019 | 810 | 0.130 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 1997 | 101 | 0.130 |
Why?
| | Proportional Hazards Models | 1 | 2019 | 1078 | 0.130 |
Why?
| | Dietary Supplements | 1 | 2019 | 459 | 0.120 |
Why?
| | Intubation, Intratracheal | 1 | 1997 | 214 | 0.120 |
Why?
| | Lung Diseases | 1 | 2021 | 690 | 0.120 |
Why?
| | Time Factors | 3 | 2021 | 6077 | 0.120 |
Why?
| | Palliative Care | 1 | 2020 | 641 | 0.120 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 907 | 0.110 |
Why?
| | Blood Pressure | 1 | 2019 | 1531 | 0.110 |
Why?
| | Wounds and Injuries | 1 | 2019 | 674 | 0.100 |
Why?
| | Adult | 3 | 2023 | 30377 | 0.100 |
Why?
| | Bile Duct Neoplasms | 1 | 2011 | 56 | 0.090 |
Why?
| | Microfilament Proteins | 2 | 2003 | 125 | 0.090 |
Why?
| | Diastole | 2 | 2022 | 137 | 0.090 |
Why?
| | Drainage | 1 | 2011 | 145 | 0.090 |
Why?
| | Purines | 2 | 2022 | 158 | 0.090 |
Why?
| | Cell Count | 1 | 2010 | 303 | 0.090 |
Why?
| | Anastomosis, Surgical | 2 | 2021 | 135 | 0.080 |
Why?
| | Actins | 2 | 2003 | 376 | 0.080 |
Why?
| | Swine | 2 | 2022 | 687 | 0.080 |
Why?
| | Cholestasis | 1 | 2011 | 225 | 0.080 |
Why?
| | Metabolome | 2 | 2021 | 274 | 0.080 |
Why?
| | Peptide Fragments | 2 | 2003 | 665 | 0.070 |
Why?
| | Carrier Proteins | 2 | 2003 | 694 | 0.070 |
Why?
| | Stents | 1 | 2011 | 466 | 0.070 |
Why?
| | Keratan Sulfate | 1 | 2006 | 1 | 0.070 |
Why?
| | Histidine | 2 | 2003 | 57 | 0.070 |
Why?
| | Synovial Fluid | 1 | 2006 | 56 | 0.070 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2006 | 132 | 0.060 |
Why?
| | Hyaluronic Acid | 1 | 2006 | 189 | 0.060 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2020 | 3254 | 0.060 |
Why?
| | Osteoarthritis | 1 | 2006 | 169 | 0.060 |
Why?
| | Cell Proliferation | 1 | 2010 | 2173 | 0.050 |
Why?
| | Erythrocyte Membrane | 1 | 2003 | 50 | 0.050 |
Why?
| | Serine | 1 | 2003 | 125 | 0.050 |
Why?
| | Binding Sites | 2 | 2003 | 1166 | 0.050 |
Why?
| | Morbidity | 1 | 2023 | 277 | 0.050 |
Why?
| | Molecular Structure | 1 | 2003 | 434 | 0.050 |
Why?
| | Amino Acid Sequence | 2 | 2003 | 1981 | 0.050 |
Why?
| | Tadalafil | 1 | 2022 | 7 | 0.050 |
Why?
| | Circulatory Arrest, Deep Hypothermia Induced | 1 | 2022 | 21 | 0.050 |
Why?
| | Phosphodiesterase 5 Inhibitors | 1 | 2022 | 36 | 0.050 |
Why?
| | Molecular Sequence Data | 2 | 2003 | 2783 | 0.050 |
Why?
| | Models, Molecular | 2 | 2003 | 1368 | 0.050 |
Why?
| | Endothelium-Dependent Relaxing Factors | 1 | 2021 | 18 | 0.050 |
Why?
| | Niacinamide | 1 | 2021 | 63 | 0.050 |
Why?
| | Arterial Pressure | 1 | 2021 | 99 | 0.040 |
Why?
| | Survival Rate | 2 | 2011 | 1638 | 0.040 |
Why?
| | Gestational Age | 1 | 2023 | 761 | 0.040 |
Why?
| | Methionine | 1 | 2021 | 144 | 0.040 |
Why?
| | Diabetic Cardiomyopathies | 1 | 2020 | 34 | 0.040 |
Why?
| | Patient-Specific Modeling | 1 | 2020 | 37 | 0.040 |
Why?
| | Systole | 1 | 2020 | 176 | 0.040 |
Why?
| | Coronary Circulation | 1 | 2020 | 134 | 0.040 |
Why?
| | Phosphorylation | 1 | 2003 | 1558 | 0.040 |
Why?
| | Principal Component Analysis | 1 | 2020 | 177 | 0.040 |
Why?
| | Drug Therapy, Combination | 1 | 2022 | 949 | 0.040 |
Why?
| | Time | 1 | 2019 | 70 | 0.040 |
Why?
| | Electrocardiography | 1 | 2022 | 561 | 0.040 |
Why?
| | Chromatography, Liquid | 1 | 2020 | 345 | 0.040 |
Why?
| | Pilot Projects | 1 | 2023 | 1360 | 0.040 |
Why?
| | Aortic Valve | 1 | 2022 | 396 | 0.040 |
Why?
| | Serotonin | 1 | 2020 | 292 | 0.040 |
Why?
| | Myocardium | 1 | 2023 | 911 | 0.040 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 1999 | 238 | 0.040 |
Why?
| | Arthritis, Rheumatoid | 1 | 2006 | 1002 | 0.040 |
Why?
| | Aorta | 1 | 2020 | 388 | 0.040 |
Why?
| | Electrophysiologic Techniques, Cardiac | 1 | 2018 | 70 | 0.040 |
Why?
| | Nevada | 1 | 1997 | 8 | 0.040 |
Why?
| | Mass Spectrometry | 1 | 2020 | 622 | 0.040 |
Why?
| | Poisson Distribution | 1 | 1997 | 71 | 0.040 |
Why?
| | Blood Flow Velocity | 1 | 2018 | 388 | 0.030 |
Why?
| | Confidence Intervals | 1 | 1997 | 302 | 0.030 |
Why?
| | Intensive Care Units, Pediatric | 1 | 1997 | 148 | 0.030 |
Why?
| | Kidney | 1 | 2022 | 1182 | 0.030 |
Why?
| | Imaging, Three-Dimensional | 1 | 2018 | 511 | 0.030 |
Why?
| | Hospital Mortality | 1 | 2018 | 773 | 0.030 |
Why?
| | Oxygen | 1 | 2018 | 851 | 0.030 |
Why?
| | Tomography, X-Ray Computed | 1 | 2023 | 2272 | 0.030 |
Why?
| | Cohort Studies | 1 | 2023 | 4883 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2021 | 4392 | 0.030 |
Why?
| | Animals | 3 | 2022 | 31565 | 0.020 |
Why?
| | Age Factors | 1 | 2018 | 2885 | 0.020 |
Why?
| | Retreatment | 1 | 2011 | 67 | 0.020 |
Why?
| | Incidence | 1 | 1997 | 2314 | 0.020 |
Why?
| | Radiography, Interventional | 1 | 2011 | 105 | 0.020 |
Why?
| | Catheterization | 1 | 2011 | 158 | 0.020 |
Why?
| | Risk Assessment | 1 | 2018 | 2958 | 0.020 |
Why?
| | Bone Morphogenetic Protein 7 | 1 | 2006 | 9 | 0.020 |
Why?
| | Young Adult | 1 | 2020 | 10446 | 0.020 |
Why?
| | Reference Values | 1 | 2006 | 739 | 0.010 |
Why?
| | Autoantigens | 1 | 2006 | 396 | 0.010 |
Why?
| | Knee Joint | 1 | 2006 | 322 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2011 | 6307 | 0.010 |
Why?
| | Titrimetry | 1 | 1999 | 9 | 0.010 |
Why?
| | Consensus Sequence | 1 | 1999 | 70 | 0.010 |
Why?
| | Static Electricity | 1 | 1999 | 112 | 0.010 |
Why?
| | Solvents | 1 | 1999 | 104 | 0.010 |
Why?
| | Chickens | 1 | 1999 | 180 | 0.010 |
Why?
| | Amino Acid Motifs | 1 | 1999 | 197 | 0.010 |
Why?
| | Protein Structure, Secondary | 1 | 1999 | 325 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1999 | 507 | 0.010 |
Why?
| | Protein Folding | 1 | 1999 | 239 | 0.010 |
Why?
| | Thermodynamics | 1 | 1999 | 380 | 0.010 |
Why?
| | Protein Binding | 1 | 1999 | 1888 | 0.010 |
Why?
| | Aged | 1 | 2011 | 18971 | 0.010 |
Why?
| | Middle Aged | 1 | 2011 | 26607 | 0.010 |
Why?
|
|
Frank's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|